Jim Cramer Calls Abbott “Really Excellent”

Abbott Laboratories (NYSE:ABT) is one of the 17 stocks that Jim Cramer commented on. During the episode, Cramer was bullish on Abbott Laboratories (NYSE:ABT) as he said, “Abbott, Charitable Trust name. That’s medical devices, okay, really excellent.”

An operating room with a doctor monitoring a patient’s vital signs during surgery with a medical device.

Abbott (NYSE:ABT) develops and sells a wide range of healthcare products, including pharmaceuticals, diagnostics, nutritionals, and medical devices for managing conditions such as cardiovascular disease, diabetes, chronic pain, and infectious diseases. Here is what the Mad Money’s host had to say about the company in the first week of May:

“Okay, their forward PE shows that there’s going to be a, pretty much of an earnings explosion. And I think a lot of that’s going to be coming from Libre, which is their diabetes, they have the best diabetes device. It’s cheaper than everybody’s.

By the way, I think pound for pound, it’s better than Dexcom, and Dexcom stock was up very big today. Also, remember, Robert Ford runs Abbott, and he runs it incredibly well. And I also think they’re going to settle these lawsuits or win the lawsuits that have really kept the lid on the stock, and that’s going to happen in 2025.”

While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.